Cheav Sotheara
SEC CIK 1721279 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ACMR | ACM Research, Inc. | See remarks | 105.4K | — | $4.44M | 16 | 2022-08-16 | 2026-06-04 |
Most active insiders at ACMR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wang David H | See Remarks, Dir, 10% | — | $28.98M |
| 2 | McKechnie Mark | See Remarks | — | $9.85M |
| 3 | Chen Fuping | See remarks | — | $3.98M |
| 4 | Liu Tracy | Dir | — | $2.85M |
| 5 | Feng Lisa | See remarks | — | $2.44M |
| 6 | Cheav Sotheara | See remarks | — | $1.59M |
| 7 | Dun Haiping | Dir | — | $954.1K |
| 8 | Pappis Charles C | Dir | — | $510.4K |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-06-05 21:00 | 2026-06-04+ | ACMR | ACM Research, Inc. | Cheav Sotheara | See remarks | M - OptEx | $13.89 | +18.8K | 105.4K | +22% | +$260.4K |
| DMT | 2026-06-05 21:00 | 2026-06-04+ | ACMR | ACM Research, Inc. | Cheav Sotheara | See remarks | S - Sale+OE | $84.58 | -18.8K | 100.0K | -16% | -$1.59M |
| DT | 2025-09-19 | 2025-09-18 | ACMR | ACM Research, Inc. | Cheav Sotheara | See remarks | S - Sale+OE | $35.00 | -10.0K | 100.0K | -9% | -$350.0K |
| DT | 2025-09-19 | 2025-09-18 | ACMR | ACM Research, Inc. | Cheav Sotheara | See remarks | M - OptEx | $13.89 | +10.0K | 110.0K | +10% | +$138.9K |
| DT | 2025-08-26 | 2025-08-22 | ACMR | ACM Research, Inc. | Cheav Sotheara | See remarks | S - Sale+OE | $30.00 | -11.2K | 100.0K | -10% | -$334.6K |
| DT | 2025-08-26 | 2025-08-22 | ACMR | ACM Research, Inc. | Cheav Sotheara | See remarks | M - OptEx | $13.89 | +11.2K | 111.2K | +11% | +$154.9K |
| DMT | 2025-02-10 | 2025-02-06 | ACMR | ACM Research, Inc. | Cheav Sotheara | See remarks | M - OptEx | $13.89 | +22.6K | 122.6K | +23% | +$313.9K |
| DT | 2025-02-10 | 2025-02-06 | ACMR | ACM Research, Inc. | Cheav Sotheara | See remarks | S - Sale+OE | $23.00 | -22.6K | 100.0K | -18% | -$519.8K |
| MT | 2024-03-15 | 2024-03-13+ | ACMR | ACM Research, Inc. | Cheav Sotheara | See remarks | S - Sale | $28.49 | -10.0K | 100.0K | -9% | -$284.9K |
| DT | 2023-11-15 | 2023-11-13 | ACMR | ACM Research, Inc. | Cheav Sotheara | See remarks | S - Sale+OE | $16.79 | -26.0K | 110.0K | -19% | -$436.5K |
| DMT | 2023-11-15 | 2023-11-13 | ACMR | ACM Research, Inc. | Cheav Sotheara | See remarks | M - OptEx | $4.99 | +26.0K | 136.0K | +24% | +$129.7K |
| DM | 2023-06-08 | 2023-06-06 | ACMR | ACM Research, Inc. | Cheav Sotheara | See remarks | M - OptEx | $4.92 | +39.0K | 149.0K | +35% | +$191.9K |
| D | 2023-06-08 | 2023-06-06 | ACMR | ACM Research, Inc. | Cheav Sotheara | See remarks | S - Sale+OE | $10.00 | -39.0K | 110.0K | -26% | -$390.0K |
| 2022-08-22 | 2022-08-18 | ACMR | ACM Research, Inc. | Cheav Sotheara | See remarks | S - Sale | $17.50 | -10.0K | 110.0K | -8% | -$175.0K | |
| DM | 2022-08-18 | 2022-08-16+ | ACMR | ACM Research, Inc. | Cheav Sotheara | See remarks | S - Sale+OE | $18.21 | -20.0K | 125.8K | -14% | -$364.2K |
| DM | 2022-08-18 | 2022-08-16+ | ACMR | ACM Research, Inc. | Cheav Sotheara | See remarks | M - OptEx | $4.62 | +10.0K | 135.0K | +8% | +$46.2K |
Purchase Sale Sale after option exercise All abbreviations